Companies aim to develop point-of-need
diagnostics to help protect farmers' fields
ALAMEDA,
Calif., Oct. 24, 2023 /PRNewswire/ -- Alveo
Technologies, Inc. today announced a collaboration with
Corteva Agriscience to expand the offering of its novel
eco-friendly molecular sensing and disease diagnostics technology
to include a first-in-field agricultural disease diagnostic.
Alveo Technologies and Corteva Agriscience
collaborate to advance molecular crop disease diagnostics
Alveo has developed a rapid, handheld, portable
medical-grade platform that pairs advanced molecular assays with
cloud-enabled data analytics for real-time disease, pathogen
analysis, and diagnosis. Using this highly sensitive multiplexed
molecular testing platform, Corteva scientists aim to design
crop-specific assays to detect pathogens in the field.
"Alveo has developed a game changing, mobile
'molecular lab' that can deliver highly sensitive and specific
diagnostic testing where it is needed, which can help solve some of
the world's most complex problems, like pandemics and global food
crises," said Alveo CEO Shaun Holt.
"Our collaboration with Corteva reflects our core focus of taking
molecular testing out of the lab and directly to the point of need
where it can deliver insight and guidance. This partnership extends
the technology beyond healthcare and into agricultural
applications."
"Corteva Agriscience explores the latest
technologies as we strive to bring actionable insights and
solutions to farmers where and when they need them," said
Gina Zastrow-Hayes, Technical
Director, Seed, R&D & Biotechnology, Corteva. "We are
pleased to explore this feasibility with Alveo and are excited by
the potential that in-field molecular testing platforms hold for
the agricultural industry."
Alveo's be.well™ platform is a point-of-care
infectious disease diagnostic platform that utilizes the company's
proprietary and globally patented method for the direct electrical
sensing of nucleic acid amplification. This technology eliminates
the need for specialized lighting and expensive optical detectors,
while also simplifying certain aspects of primer manufacturing,
providing a more robust and reliable diagnostic
instrument. Corteva scientists will explore three components
of the platform to develop agri-based assays: the be.well™
Analyzer, a portable, palm-sized, rechargeable device; the be.well™
Cartridge which contains the reagents required for an isothermal
amplification reaction; and the be.well Mobile App which offers
step by step guidance on administering the test, cloud-connectivity
for reporting and tracking results, and back-end analytics for
deeper insights into pathogen behavior.
This collaboration reflects both companies'
open-source philosophy and desire to build together across sectors
and technologies.
About Alveo
At Alveo, we strive to
improve outcomes by making molecular detection and diagnostics
universally accessible – whether that means on the farm, in the
clinic, or even within industrial processes. We understand the
value of detecting pathogens earlier where decisions and results
can be most effective and impactful. Alveo's be.well™ platform
technology encompasses a unique method of nucleic acid
amplification coupled with our proprietary direct electrical
sensors, enabling improved outcomes across numerous market sectors
and verticals at the point of need. Our platform was designed from
the bottom up to enable detection and diagnosis of pathogens
earlier given its portability, ease of use, robust and rugged
design, multiplexing capability, high accuracy, coupled with fast
times to result. Cloud connected and Bluetooth enabled, advanced
data and analytics are available for reportable diseases, and
monitoring and surveillance of new and emerging pathogens. Our aim
is to help customers and patients prevent or significantly limit
the negative, destructive impact viruses, fungi, bacteria, and
other pathogens can have on our planet. In doing so, we are
providing actionable insights at lightspeed, improving health
outcomes, saving time, reducing cost, and improving yields. With
Alveo, we Know Sooner, Act Faster™.
To learn more, visit
https://alveotechnologies.com
About Corteva
Corteva, Inc.
(NYSE: CTVA) is a publicly traded, global pure-play agriculture
company that combines industry-leading innovation, high-touch
customer engagement and operational execution to profitably deliver
solutions for the world's most pressing agriculture challenges.
Corteva generates advantaged market preference through its unique
distribution strategy, together with its balanced and globally
diverse mix of seed, crop protection, and digital products and
services. With some of the most recognized brands in agriculture
and a technology pipeline well positioned to drive growth, the
company is committed to maximizing productivity for farmers, while
working with stakeholders throughout the food system as it fulfills
its promise to enrich the lives of those who produce and those who
consume, ensuring progress for generations to come. More
information can be found at www.corteva.com
Follow Corteva on Facebook, Instagram, LinkedIn,
Twitter and YouTube.
Cautionary Statement on Forward-looking
Statements
This release contains certain estimates and
forward-looking statements within the meaning of Section 21E of the
Securities Exchange Act of 1934, as amended, and Section 27A of the
Securities Act of 1933, as amended, which are intended to be
covered by the safe harbor provisions for forward-looking
statements contained in the Private Securities Litigation Reform
Act of 1995, and may be identified by their use of words like
"plans," "expects," "will," "anticipates," "believes," "intends,"
or other words of similar meaning. All statements that address
expectations or projections about the future, including statements
about Corteva's regulatory approvals, product development, product
offerings and expected performance are forward-looking statements.
Corteva disclaims and does not undertake any obligation to update
or revise any forward-looking statement, except as required by
applicable law. A detailed discussion of some of the significant
risks and uncertainties which may cause results and events to
differ materially from such forward-looking statements or other
estimates is included in the "Risk Factors" section of Corteva's
Annual Report on Form 10-K, as modified by subsequent reports on
Form 10-Q and Current Reports on Form 8-K.
Media Contact:
Jeff
Miller
Market Street Group for Alveo Technologies, Inc.
alveo@marketstreetgrp.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alveo-technologies-and-corteva-agriscience-collaborate-to-advance-molecular-crop-disease-diagnostics-and-improve-crop-yields-301965262.html
SOURCE Alveo Technologies